BRCA1 and BRCA2 Flashcards
T or F: most breast/ovarian cancer is caused by heritable mutations
False, most of these cancers arise sporadically
What kind of proteins do the BRCA1 and BRCA2 genes code for?
TUMOR SUPPRESSOR GENES - codes for proteins that are important for responding to DNA damage and maintenance of gene integrity
What is HBOC?
Hereditary Breast and Ovarian Cancer
T or F: patients with HBOC are heterozygous for a mutation in BRCA1 or BRCA2 but NOT BOTH.
True
What chromosomes are BRCA1 and BRCA2 located on?
BRCA1:
Chromosome 17
BRCA2:
Chromosome 13
T or F: women must be homozygous to be affected by BRCA gene mutations
False, heterozygous individuals are affected
**AUTOSOMAL DOMINANT
What is the population risk of breast cancer?
- BRCA1 risk
- BRCA2 risk
Population:
1 in 10
BRCA1:
6 in 10
BRCA2:
4 in 10
**Women heterozygous for BRCA1/2 are at a much elevated risk even over population risk
What is reduced penetrance?
- how does is apply to BRCA1/2
Carrying the BRCA1/2 Allele does not necessarily mean that cancer will develop in that individual.
What is variable expressivity?
- how does it apply to BRCA1/2
- A parent may have a BRCA1/2 mutation, die of BREAST CANCER and pass that mutation to offspring.
- Offspring may die of OVARIAN cancer or some other type related to the BRCA1/2 gene
**Disease will manifest itself in different ways
What are 2 reasons for reduced penetrance in individuals with a BRCA1/2 mutation?
- Disease may just never manifest
2. Typical late onset of breast cancer may mean the individual dies of something else before breast cancer developes
What is the average penetrance of BRCA1/2?
BRCA1 = 6/10 develop cancer BRCA2 = 4/10 develop cancer
Overall penetrance = 50%
What approach is used used to detect mutations in the BRCA1/2 genes?
- why is this necessary?
- Scanning SEQUENCING approach usually paired with an ARRAY
- used because of the large number of mutations on the BRCA1/2 genes
***These mutations are mostly point mutations they why a SEQUENCING approach is most useful
With the large amount of information obtained from the scanning approach, how do you determine if mutations are meaningful or just typical benign polymorphisms?
- Pathogenic Variants have been documented
**Those not known to be benign or pathogenic are given the label of UNCERTAIN SIGNIFICANCE
T or F: mutations to the BRCA1/2 genes often results in loss of function
True
T or F: BRCA1/2 are always sequenced together
True